Literature DB >> 9463

Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0.

B G Rao, M W Spence.   

Abstract

A hitherto undescribed sphingomyelinase (sph'ase 7.4) of human brain has been studied in crude and partially purified (3- to 4- fold) extracts of grey matter, and compared to the known sphingomyelinase with an acid pH optimum (sph'ase 5.0). Its specificity for sphingomyelin as substrate is similar to that of sph'ase 5.0, but it differs from sph'ase 5.0 in its pH optimum (7.4 vs 5.0) and in a requirement for Mg2+ for optimal activity. Other properties of sph'ase 7.4 that distinguish it from sph'ase 5.0 include (a) its lack of appreciable solubilization during dialysis of crude homogenates (b) a more marked concentrations in grey matter than in white matter (9- to 13- fold vs 1.5- to 2-fold for sph'ase 5.0); (c) inhibition by Ca2+ and Cd2+ ions, and by EDTA; (D) stimulation by dithiothreitol, and inhibition by cysteine, N-ethylmaleimide, and p-hydroxymercuribenzoate; (e) lack of inhibition by nucleotides (AMP.ADP, and ATP) and by NAD plus NADH; and (f) relative instability to storage or manipulation between -20degrees C and 40degrees C. These differences indicate the SPH'ASE 7.4 is a different enzyme protein from sph'ase 5.0. Unlike sph'ase 5.0, which is widely distributed in mammalian tissues, sph'ase 7.4 occurs predominantly in grey matter and little activity was observed is spleen, liver, or leukocytes. The high levels of this enzyme in brain suggest a role related to the specific functions of this organ or to the need for a more stringent control of sphingomyelin catabolism in brain as compared to other organs.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9463

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  26 in total

1.  Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis.

Authors:  Vincent Mignard; Nolwenn Dubois; Didier Lanoé; Marie-Pierre Joalland; Lisa Oliver; Claire Pecqueur; Dominique Heymann; François Paris; François M Vallette; Lisenn Lalier
Journal:  J Lipid Res       Date:  2020-04-29       Impact factor: 5.922

Review 2.  The neutral sphingomyelinase family: identifying biochemical connections.

Authors:  Christopher J Clarke; Bill X Wu; Yusuf A Hannun
Journal:  Adv Enzyme Regul       Date:  2010-10-28

3.  In vitro and in vivo activities of arachidonic acid against Schistosoma mansoni and Schistosoma haematobium.

Authors:  Rashika El Ridi; Marwa Aboueldahab; Hatem Tallima; Mohamed Salah; Noha Mahana; Samia Fawzi; Shadia H Mohamed; Omar M Fahmy
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

4.  An unusual phosphodiesterase activity towards p-nitrophenylphosphorylcholine present in rat brain membranes.

Authors:  J N Kanfer; D McCartney
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

5.  Interindividual heterogeneity of molecular weight of human brain neutral sphingomyelinase determined by radiation inactivation method.

Authors:  T Levade; R Salvayre; M Potier; L Douste-Blazy
Journal:  Neurochem Res       Date:  1986-08       Impact factor: 3.996

6.  Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice.

Authors:  Nino Tabatadze; Alena Savonenko; Hongjun Song; Veera Venkata Ratnam Bandaru; Michael Chu; Norman J Haughey
Journal:  J Neurosci Res       Date:  2010-10       Impact factor: 4.164

7.  Identification and partial characterization of an acidic sphingomyelinase (SMase) from cultured human umbilical vein endothelial cells (HUVEC).

Authors:  J F Truax; F R Cochran
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

8.  Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.

Authors:  Takeshi Yabu; Shintaro Imamura; Michiaki Yamashita; Toshiro Okazaki
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

9.  The role of sphingomyelin in phosphatidylcholine metabolism in cultured human fibroblasts from control and sphingomyelin lipidosis patients and in Chinese hamster ovary cells.

Authors:  M W Spence; H W Cook; D M Byers; F B Palmer
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

10.  Deficiency of taurocholate-dependent phospholipase C acting on phosphatidylcholine in Niemann-Pick disease.

Authors:  J R Wherrett; S Huterer
Journal:  Neurochem Res       Date:  1983-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.